PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 25338565-8 2014 It is concluded that GSK525762A can inhibit the proliferation of KU812 cells and induce cell apoptosis possibly through depressing the transcription of C-MYC, BCL-2, CDK6 and BCL-xL gene, and down-regulating BAK and BAX transcription. molibresib 21-31 BCL2 antagonist/killer 1 Homo sapiens 208-211 25338565-0 2014 [Effect of BRD4 inhibitor GSK525762A on proliferation and apoptosis of KU812 leukemic cells and its mechanism]. molibresib 26-36 bromodomain containing 4 Homo sapiens 11-15 25338565-1 2014 This study was purposed to investigate the effect of bromodomain-containing protein 4 (BRD4) inhibitor GSK525762A on the proliferation and apoptosis of chronic myeloid leukemia blast crisis KU812 cells and its mechanism. molibresib 103-113 bromodomain containing 4 Homo sapiens 53-85 25338565-1 2014 This study was purposed to investigate the effect of bromodomain-containing protein 4 (BRD4) inhibitor GSK525762A on the proliferation and apoptosis of chronic myeloid leukemia blast crisis KU812 cells and its mechanism. molibresib 103-113 bromodomain containing 4 Homo sapiens 87-91 25338565-7 2014 After GSK525762A treatment, the mRNA levels of proliferation-promoting genes ( C-MYC and CDK6) and pro-survival genes ( BCL-2 and BCL-xL) decreased, while the transcription level of pro-apoptosis genes BAK and BAX increased, as compared to that of the control group. molibresib 6-16 MYC proto-oncogene, bHLH transcription factor Homo sapiens 79-84 25338565-7 2014 After GSK525762A treatment, the mRNA levels of proliferation-promoting genes ( C-MYC and CDK6) and pro-survival genes ( BCL-2 and BCL-xL) decreased, while the transcription level of pro-apoptosis genes BAK and BAX increased, as compared to that of the control group. molibresib 6-16 cyclin dependent kinase 6 Homo sapiens 89-93 25338565-7 2014 After GSK525762A treatment, the mRNA levels of proliferation-promoting genes ( C-MYC and CDK6) and pro-survival genes ( BCL-2 and BCL-xL) decreased, while the transcription level of pro-apoptosis genes BAK and BAX increased, as compared to that of the control group. molibresib 6-16 BCL2 apoptosis regulator Homo sapiens 120-125 25338565-7 2014 After GSK525762A treatment, the mRNA levels of proliferation-promoting genes ( C-MYC and CDK6) and pro-survival genes ( BCL-2 and BCL-xL) decreased, while the transcription level of pro-apoptosis genes BAK and BAX increased, as compared to that of the control group. molibresib 6-16 BCL2 like 1 Homo sapiens 130-136 25338565-7 2014 After GSK525762A treatment, the mRNA levels of proliferation-promoting genes ( C-MYC and CDK6) and pro-survival genes ( BCL-2 and BCL-xL) decreased, while the transcription level of pro-apoptosis genes BAK and BAX increased, as compared to that of the control group. molibresib 6-16 BCL2 antagonist/killer 1 Homo sapiens 202-205 25338565-7 2014 After GSK525762A treatment, the mRNA levels of proliferation-promoting genes ( C-MYC and CDK6) and pro-survival genes ( BCL-2 and BCL-xL) decreased, while the transcription level of pro-apoptosis genes BAK and BAX increased, as compared to that of the control group. molibresib 6-16 BCL2 associated X, apoptosis regulator Homo sapiens 210-213 25338565-8 2014 It is concluded that GSK525762A can inhibit the proliferation of KU812 cells and induce cell apoptosis possibly through depressing the transcription of C-MYC, BCL-2, CDK6 and BCL-xL gene, and down-regulating BAK and BAX transcription. molibresib 21-31 MYC proto-oncogene, bHLH transcription factor Homo sapiens 152-157 25338565-8 2014 It is concluded that GSK525762A can inhibit the proliferation of KU812 cells and induce cell apoptosis possibly through depressing the transcription of C-MYC, BCL-2, CDK6 and BCL-xL gene, and down-regulating BAK and BAX transcription. molibresib 21-31 BCL2 apoptosis regulator Homo sapiens 159-164 25338565-8 2014 It is concluded that GSK525762A can inhibit the proliferation of KU812 cells and induce cell apoptosis possibly through depressing the transcription of C-MYC, BCL-2, CDK6 and BCL-xL gene, and down-regulating BAK and BAX transcription. molibresib 21-31 cyclin dependent kinase 6 Homo sapiens 166-170 25338565-8 2014 It is concluded that GSK525762A can inhibit the proliferation of KU812 cells and induce cell apoptosis possibly through depressing the transcription of C-MYC, BCL-2, CDK6 and BCL-xL gene, and down-regulating BAK and BAX transcription. molibresib 21-31 BCL2 like 1 Homo sapiens 175-181 25338565-8 2014 It is concluded that GSK525762A can inhibit the proliferation of KU812 cells and induce cell apoptosis possibly through depressing the transcription of C-MYC, BCL-2, CDK6 and BCL-xL gene, and down-regulating BAK and BAX transcription. molibresib 21-31 BCL2 associated X, apoptosis regulator Homo sapiens 216-219